Results 1 to 10 of about 1,553,841 (335)

Successful treatment of large-cell neuroendocrine carcinoma of the prostate with pembrolizumab: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Large-cell neuroendocrine carcinoma of the prostate is an extremely rare disease and classified into two subtypes: de novo and treatment-induced large-cell neuroendocrine carcinoma that arises from adenocarcinoma via lineage plasticity in ...
Erika Yamashita   +11 more
doaj   +2 more sources

A case report of primary large cell neuroendocrine carcinoma of the urinary bladder [PDF]

open access: yesUrology Case Reports
Neuroendocrine carcinoma (NEC) is a highly malignant tumor that originates from neuroendocrine cells, most commonly found in the gastrointestinal tract and lungs.
Yuan Liu, Qi Wang
doaj   +2 more sources

Neuroendocrine Cervical Carcinoma

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2023
Objective: To present a series of neuroendocrine cervical carcinoma, a rare malignancy of the cervix with different stages, treatment approach and outcome.
Yulian Prastisia   +3 more
doaj   +3 more sources

Hepatic metastasis of pulmonary large cell neuroendocrine carcinoma: A case report and literature review [PDF]

open access: yesJournal of International Medical Research
Large cell neuroendocrine carcinoma of the lung is a rare and aggressive malignancy with a high propensity for metastasis. This carcinoma demonstrates a significantly higher propensity for hepatic metastasis compared with other non-small cell lung cancer
Jiake Wu   +5 more
doaj   +2 more sources

Primary large-cell neuroendocrine carcinoma of the prostate [PDF]

open access: yesArchives of the Balkan Medical Union, 2022
Introduction. Depending on neuroendocrine differentiation, the prostate cancer is divided into two major groups: primary neuroendocrine prostate tumour (carcinoid, small-cell, and large-cell neuroendocrine carcinoma) or as a focal tumour in conventional ...
Spasimir T. SHOPOV
doaj   +1 more source

Metastatic neuroendocrine carcinoma to the mandibular gingiva from the duodenum papilla

open access: yesOral Oncology Reports, 2023
Neuroendocrine carcinoma is a high-grade carcinoma with morphological and immunohistochemical features of neuroendocrine differentiation. Poorly differentiated neuroendocrine carcinoma which has two subtypes (small cell or large cell type) is extremely ...
Toshinori Iwai   +3 more
doaj   +1 more source

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

open access: yesJournal of neuroendocrinology, 2023
This ENETS guidance paper, developed by a multidisciplinary working group, provides up‐to‐date and practical advice on the diagnosis and management of digestive neuroendocrine carcinoma, based on recent developments and study results.
H. Sørbye   +10 more
semanticscholar   +1 more source

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System

open access: yesJAMA Oncology, 2022
This randomized clinical trial assesses whether etoposide plus cisplatin or irinotecan plus cisplatin is a more effective treatment regimen in terms of overall survival in patients with advanced neuroendocrine carcinoma of the digestive system.
C. Morizane   +20 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy